These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30580275)

  • 1. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 7. Health literacy levels and views about being invited to a colorectal cancer screening program.
    Wangmar J; Jervaeus A; Fritzell K; Wångdahl J; Hultcrantz R; Wengström Y
    Acta Oncol; 2018 Jun; 57(6):743-749. PubMed ID: 29308944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial.
    de Wijkerslooth TR; de Haan MC; Stoop EM; Bossuyt PM; Thomeer M; Essink-Bot ML; van Leerdam ME; Fockens P; Kuipers EJ; Stoker J; Dekker E
    Gut; 2012 Nov; 61(11):1552-9. PubMed ID: 22198714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does theory of planned behaviour play a role in predicting uptake of colorectal cancer screening? A cross-sectional study in Hong Kong.
    Huang J; Wang J; Pang TW; Chan MK; Leung S; Chen X; Leung C; Zheng ZJ; Wong MC
    BMJ Open; 2020 Aug; 10(8):e037619. PubMed ID: 32764087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different information needs-The major reasons for calling the helpline when invited to colorectal cancer screening.
    Fritzell K; Kottorp A; Jervaeus A
    Health Expect; 2022 Aug; 25(4):1548-1554. PubMed ID: 35393757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-making about participation in colorectal cancer screening in Sweden: Autonomous, value-dependent but uninformed?
    Wangmar J; Wengström Y; Jervaeus A; Hultcrantz R; Fritzell K
    Patient Educ Couns; 2021 Apr; 104(4):919-926. PubMed ID: 32980202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of people's values and preferences for colorectal cancer screening participation.
    Fritzell K; Stake Nilsson K; Jervaeus A; Hultcrantz R; Wengström Y
    Eur J Public Health; 2017 Dec; 27(6):1079-1084. PubMed ID: 28160484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
    Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
    Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.